Newleos Therapeutics, Inc.
Clinical trials sponsored by Newleos Therapeutics, Inc., explained in plain language.
-
New pill aims to curb alcohol cravings in heavy drinkers
Disease control Recruiting nowThis early-stage study tests an experimental drug called NTX-2001 in 50 adults with Alcohol Use Disorder. Participants take the drug or a placebo daily for two weeks to see if it reduces alcohol consumption and is safe. The goal is to find a new treatment option for people who st…
Phase: PHASE1 • Sponsor: Newleos Therapeutics, Inc. • Aim: Disease control
Last updated Jun 08, 2026 13:13 UTC
-
New pill could ease social anxiety in weeks
Symptom relief Recruiting nowThis study tests a new drug called NTX-1472 in 100 adults with social anxiety disorder. Participants take the drug or a placebo daily for 8 weeks and have 6 clinic visits over 14 weeks. The goal is to see if the drug is safe and reduces anxiety symptoms.
Phase: PHASE2 • Sponsor: Newleos Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 10, 2026 13:25 UTC